• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同组织学类型卵巢癌中端粒长度的研究,重点为透明细胞癌。

Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.

机构信息

Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MA 21231, USA.

出版信息

Mod Pathol. 2011 Aug;24(8):1139-45. doi: 10.1038/modpathol.2011.67. Epub 2011 Apr 15.

DOI:10.1038/modpathol.2011.67
PMID:21499239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4763925/
Abstract

Ovarian carcinoma is composed of a heterogeneous group of tumors with distinct clinico-pathological and molecular features. Alteration of telomerase activity has been reported in ovarian tumors but the pattern of telomere length in their specific histological subtypes has not been reported. In this study, we performed quantitative telomere fluorescence in situ hybridization on a total of 219 ovarian carcinomas including 106 high-grade serous carcinomas, 26 low-grade serous carcinomas, 56 clear cell carcinomas and 31 low-grade endometrioid carcinomas. The mean relative telomere length of carcinoma to stromal cells was calculated as a telomere index. This index was significantly higher in clear cell carcinoma compared with the other histologic types (P=0.007). Overall there was no association between the telomere index and mortality, but when stratified by histologic types, the hazard ratio for death among women with clear cell carcinoma with a telomere index >1 was significantly increased at 4.93 (95% CI 1.64-14.86, P=0.005) when compared with those with a telomere index ≤1. In conclusion, our results provide new evidence that telomere length significantly differs by histologic type in ovarian carcinoma. Specifically, clear cell carcinomas have longer mean relative telomere lengths compared with the other histologic types and longer telomeres in clear cell carcinoma are associated with increased mortality suggesting that aberrations in telomere length may have an important role in the development and progression of this neoplasm.

摘要

卵巢癌由一组具有不同临床病理和分子特征的肿瘤组成。已经报道了端粒酶活性在卵巢肿瘤中的改变,但它们特定组织学亚型中端粒长度的模式尚未报道。在这项研究中,我们对总共 219 例卵巢癌进行了定量端粒荧光原位杂交,包括 106 例高级别浆液性癌、26 例低级别浆液性癌、56 例透明细胞癌和 31 例低级别子宫内膜样癌。计算癌与基质细胞的相对端粒长度的平均值作为端粒指数。与其他组织学类型相比,透明细胞癌的端粒指数显著更高(P=0.007)。总体而言,端粒指数与死亡率之间没有关联,但按组织学类型分层时,端粒指数>1 的透明细胞癌患者的死亡风险比端粒指数≤1 的患者显著增加,危险比为 4.93(95%CI 1.64-14.86,P=0.005)。总之,我们的结果提供了新的证据,表明卵巢癌中端粒长度在组织学类型上有显著差异。具体来说,与其他组织学类型相比,透明细胞癌的平均相对端粒长度更长,透明细胞癌中较长的端粒与死亡率增加相关,这表明端粒长度的异常可能在这种肿瘤的发生和进展中起着重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e5/4763925/0960df4f2233/nihms756958f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e5/4763925/5a6f27c904d0/nihms756958f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e5/4763925/0c87cd363d1e/nihms756958f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e5/4763925/0960df4f2233/nihms756958f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e5/4763925/5a6f27c904d0/nihms756958f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e5/4763925/0c87cd363d1e/nihms756958f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e5/4763925/0960df4f2233/nihms756958f3.jpg

相似文献

1
Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.不同组织学类型卵巢癌中端粒长度的研究,重点为透明细胞癌。
Mod Pathol. 2011 Aug;24(8):1139-45. doi: 10.1038/modpathol.2011.67. Epub 2011 Apr 15.
2
Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.卵巢透明细胞癌中存在高频端粒酶逆转录酶启动子体细胞突变,但在其他主要妇科恶性肿瘤中不存在。
J Pathol. 2014 Mar;232(4):473-81. doi: 10.1002/path.4315.
3
Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types.胰岛素样生长因子结合蛋白2和5在不同组织学类型的卵巢癌中受到不同程度的调控。
Mod Pathol. 2006 Sep;19(9):1149-56. doi: 10.1038/modpathol.3800637. Epub 2006 May 26.
4
Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.子宫内膜异位症并不会改善同源型卵巢癌的预后。
Am J Surg Pathol. 2012 May;36(5):688-95. doi: 10.1097/PAS.0b013e31824b6eed.
5
Gene expression profiles in three histologic types, clear-cell, endometrioid and serous ovarian carcinomas.三种组织学类型(透明细胞型、子宫内膜样型和浆液性卵巢癌)中的基因表达谱。
J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):659-74.
6
Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation.子宫内膜和卵巢透明细胞癌中的分子改变:端粒酶逆转录酶启动子突变的临床影响。
Mod Pathol. 2015 Feb;28(2):303-11. doi: 10.1038/modpathol.2014.93. Epub 2014 Aug 1.
7
Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.卵巢癌的形态学亚型:新进展和发病机制综述。
Pathology. 2011 Aug;43(5):420-32. doi: 10.1097/PAT.0b013e328348a6e7.
8
Associations between residual disease and survival in epithelial ovarian cancer by histologic type.不同组织学类型上皮性卵巢癌中残余病灶与生存的相关性。
Gynecol Oncol. 2017 Nov;147(2):250-256. doi: 10.1016/j.ygyno.2017.08.003. Epub 2017 Aug 16.
9
CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis.CCNE1基因拷贝数增加和过表达可识别预后不良的卵巢透明细胞癌。
Mod Pathol. 2017 Feb;30(2):297-303. doi: 10.1038/modpathol.2016.160. Epub 2016 Oct 21.
10
Activation of c-erbB-2 and prognosis in ovarian carcinoma. Comparison with histologic type, grade, and stage.c-erbB-2激活与卵巢癌预后。与组织学类型、分级及分期的比较。
Cancer. 1994 Mar 1;73(5):1460-6. doi: 10.1002/1097-0142(19940301)73:5<1460::aid-cncr2820730523>3.0.co;2-z.

引用本文的文献

1
The -124C>T Mutation of the Promoter Indicates Favorable Prognosis in Ovarian Clear Cell Carcinoma: A Single Institutional Study in China.启动子-124C>T突变提示卵巢透明细胞癌预后良好:一项中国单中心研究
Curr Oncol. 2025 Jul 27;32(8):422. doi: 10.3390/curroncol32080422.
2
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.端粒、端粒酶与癌症:作用机制、生物标志物及治疗方法
Exp Hematol Oncol. 2025 Jan 27;14(1):8. doi: 10.1186/s40164-025-00597-9.
3
Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma.端粒长度作为卵巢癌患者治疗反应和生存的预测指标。
Heliyon. 2024 Jun 29;10(13):e33525. doi: 10.1016/j.heliyon.2024.e33525. eCollection 2024 Jul 15.
4
Role of telomere length in human carcinogenesis (Review).端粒长度在人类肿瘤发生中的作用(综述)。
Int J Oncol. 2023 Jul;63(1). doi: 10.3892/ijo.2023.5526. Epub 2023 May 26.
5
PAX8, an Emerging Player in Ovarian Cancer.PAX8,卵巢癌的新兴参与者。
Adv Exp Med Biol. 2021;1330:95-112. doi: 10.1007/978-3-030-73359-9_6.
6
The association of female and male infertility with telomere length (Review).女性和男性不孕与端粒长度的关联(综述)。
Int J Mol Med. 2019 Aug;44(2):375-389. doi: 10.3892/ijmm.2019.4225. Epub 2019 May 31.
7
Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.高危人群的输卵管病变与卵巢癌:一项多中心研究。
Cancer Prev Res (Phila). 2018 Nov;11(11):697-706. doi: 10.1158/1940-6207.CAPR-18-0009. Epub 2018 Sep 19.
8
TGFβ Controls Ovarian Cancer Cell Proliferation.转化生长因子β控制卵巢癌细胞的增殖。
Int J Mol Sci. 2017 Jul 30;18(8):1658. doi: 10.3390/ijms18081658.
9
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.鉴定上皮性卵巢癌不同组织学类型的12个新的易感基因座。
Nat Genet. 2017 May;49(5):680-691. doi: 10.1038/ng.3826. Epub 2017 Mar 27.
10
Association between telomere length and survival in cancer patients: a meta-analysis and review of literature.癌症患者端粒长度与生存之间的关联:一项荟萃分析及文献综述
Front Med. 2016 Jun;10(2):191-203. doi: 10.1007/s11684-016-0450-2. Epub 2016 May 16.

本文引用的文献

1
ARID1A mutations in endometriosis-associated ovarian carcinomas.ARID1A 突变与子宫内膜异位症相关的卵巢癌。
N Engl J Med. 2010 Oct 14;363(16):1532-43. doi: 10.1056/NEJMoa1008433. Epub 2010 Sep 8.
2
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.卵巢透明细胞癌中染色质重塑基因 ARID1A 的频繁突变。
Science. 2010 Oct 8;330(6001):228-31. doi: 10.1126/science.1196333. Epub 2010 Sep 8.
3
Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis.在浆液性输卵管上皮内癌中,端粒缩短:卵巢高级别浆液性癌发生的早期事件。
Am J Surg Pathol. 2010 Jun;34(6):829-36. doi: 10.1097/PAS.0b013e3181dcede7.
4
DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma.亲和纯化卵巢透明细胞癌的 DNA 拷贝数谱。
Clin Cancer Res. 2010 Apr 1;16(7):1997-2008. doi: 10.1158/1078-0432.CCR-09-2105. Epub 2010 Mar 16.
5
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.TP53 基因突变在卵巢高级别浆液性癌中普遍存在。
J Pathol. 2010 May;221(1):49-56. doi: 10.1002/path.2696.
6
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.上皮性卵巢癌的起源和发病机制:一种提出的统一理论。
Am J Surg Pathol. 2010 Mar;34(3):433-43. doi: 10.1097/PAS.0b013e3181cf3d79.
7
Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma.卵巢癌亚型(除高级别浆液性癌外)中的分子异常。
J Oncol. 2010;2010:740968. doi: 10.1155/2010/740968. Epub 2009 Dec 30.
8
Current status of gynecologic cancer in Japan.日本妇科癌症的现状。
J Gynecol Oncol. 2009 Jun;20(2):67-71. doi: 10.3802/jgo.2009.20.2.67. Epub 2009 Jun 29.
9
Telomere uncapping, chromosomes, and carcinomas.端粒解帽、染色体与癌症
Cancer Cell. 2009 Jun 2;15(6):455-7. doi: 10.1016/j.ccr.2009.05.006.
10
Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas.卵巢浆液性肿瘤中DNA拷贝数改变的分析揭示了低级别和高级别癌中新的分子遗传学变化。
Cancer Res. 2009 May 1;69(9):4036-42. doi: 10.1158/0008-5472.CAN-08-3913. Epub 2009 Apr 21.